Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line

Drug Metabolism and Disposition

Volumn 33, Issue 4, 2005, Pages 547-554

  Tian, Run ^a   Koyabu, Noriko ^a   Morimoto, Satoshi ^a   Shoyama, Yukihiro ^a   Ohtani, Hisakazu ^a   Sawada, Yasufumi ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; HYPERFORIN; HYPERICIN; HYPERICUM PERFORATUM EXTRACT;

ARTICLE; CANCER CELL CULTURE; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; DRUG TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN INDUCTION; TRANSPORT KINETICS; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BICYCLO COMPOUNDS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIGOXIN; HUMANS; HYPERICUM; LLC-PK1 CELLS; P-GLYCOPROTEIN; PERYLENE; PHLOROGLUCINOL; PLANT EXTRACTS; RIFAMPIN; SWINE; TERPENES; TRANSFECTION;

EID: 15344351655     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.002485     Document Type: Article

References (31)

1. Bauer S, Störmer E, Johne A, Krüger H, Budde K, Neumayer H, Roots I, and Mai I (2002) Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol 55:203-211.
2. Brantner A, Kartnig TH, and Quehenberger F (1994) Vergleichende phytochemische Untersuchungen an Hypericum perforatum L. und Hypericum maculatum Crantz. Sci Pharm 62:261-276.
3. Breidenbach TH, Hoffmann MW, Becker TH, Schlitt H, and Klempnauer J (2000) Drug interaction of St John's wort with ciclosporin. Lancet 355:1912.
4. Butterweck V, Petereit F, Winterhoff H, and Nahrstedt A (1998) Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the Forced Swimming Test. Planta Med 64:291-294.
5. Chatterjee SS, Bhattacharrya SK, Wonnemann M, Singer A, and Müller WE (1998) Hyperforin as a possible antidepressant component of Hypericum extracts. Life Sci 63:499-510.
6. Dürr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, and Fattinger K (2000) St John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68:598-604.
7. Erdelmeier CA (1998) Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L. Pharmacopychiatry 31 (Suppl 1):2-6.
8. Ernst E (1999) Second thoughts about safety of St John's wort. Lancet 354:2014-2016.
9. Geick A, Eichelbaum M, and Burk O (2001) Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J Biol Chem 276:14581-14587.
10. Greiner R, Eichelbaum M, Fritz P, Kreichgauer HP, Von Richter O, and Zundler J (1999) The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Investig 104:147-153.
11. Hamman MA, Craven R, Bruce MA, Haehner-Daniels BD, and Hall SD (2001) The effect of rifampicin administration on the disposition of fexofenadine. Clin Pharmacol Ther 69:114-121.
12. Herzog CE, Tsokos M, Bates SE, and Fojo AT (1993) Increased mdr-1/P/glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268:2946-2952.
13. Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, and Roots I (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 66:338-345.
14. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, and Hagenbuch B (2001) Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525-533.
15. Lacarelle B, Rahmani R, De Sousa G, Durand A, Placidi M, and Cano JP (1991) Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundam Clin Pharmacol 1991:567-582.
16. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Land) 227:680-685.
17. Lin JH, Chiba M, Chen IW, Nishime JA, Deluna FA, Yamazaki M, and Lin YJ (1999) Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and P-glycoprotein induction. Drug Metab Dispos 27:1187-1193.
18. Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, and Melchart D (1996) St John's wort for depression-an overview and meta-analysis of randomised clinical trials. Br Med J 313:253-258.
19. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ ( 1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
20. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Millson TM, Collins JL, and Kliewer SA (2000) St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500-7502.
21. Perloff MD, Von Moltke LL, Störmer E, Shader RI, and Greenblatt DJ (2001) Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 134:1601-1608.
22. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, and Falloon J (2000) Indinavir concentrations and St John's Wort. Lancet 355:547-548.
23. Roby CA, Anderson GD, Kantor E, Dryer DA, and Burstein AH (2000) St John's wort: effect on CYP3A4 activity. Clin Pharmacol Ther 67:451-457.
24. Ruschitzka F, Meier PJ, Turina M, Luscher TF, and Noll G (2000) Acute heart transplant rejection due to Saint John's Wort. Lancet 355:548-549.
25. Seifeldin R (1995) Drug interaction in transplantation. Clin Ther 17:1043-1061.
26. Su SF and Huang JD (1996) Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab Dispos 24:142-147.
27. Synold TW, Dussault I, and Forman BM (2001) The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat Med 7:584-590.
28. Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, and Hori R (1992) Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1) J Pharmacol Exp Ther 263:840-845.
29. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, and Schuetz E (2001) Transcriptional control of intestinal cytochrome P-4503A by 1-alpha,25-dihydroxy vitamin D3. Mol Pharmacol 60:1399-1406.
30. Wang Z, Hamman MA, Huang S, Lesko LJ, and Hall SD (2002) Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 71:414-420.
31. Wheatley D (1998) Hypericum extract. Potential in the treatment of depression. CNS Drugs 9:431-440.